1276 related articles for article (PubMed ID: 18621039)
1. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
dos Reis LM; Canto-de-Souza A
Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
[TBL] [Abstract][Full Text] [Related]
2. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
Mendes-Gomes J; Nunes-de-Souza RL
Brain Res; 2005 Jun; 1047(1):97-104. PubMed ID: 15893297
[TBL] [Abstract][Full Text] [Related]
3. Blockade of fear-induced antinociception with intra-amygdala infusion of midazolam: Influence of prior test experience.
Baptista D; Bussadori K; Nunes-de-Souza RL; Canto-de-Souza A
Brain Res; 2009 Oct; 1294():29-37. PubMed ID: 19635465
[TBL] [Abstract][Full Text] [Related]
4. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice.
Miguel TT; Nunes-de-Souza RL
Brain Res; 2008 Nov; 1240():39-46. PubMed ID: 18793618
[TBL] [Abstract][Full Text] [Related]
5. 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.
Nunes-de-Souza V; Nunes-de-Souza RL; Rodgers RJ; Canto-de-Souza A
Behav Brain Res; 2008 Feb; 187(1):72-9. PubMed ID: 17935799
[TBL] [Abstract][Full Text] [Related]
6. The anterior cingulate cortex is a target structure for the anxiolytic-like effects of benzodiazepines assessed by repeated exposure to the elevated plus maze and Fos immunoreactivity.
Albrechet-Souza L; Borelli KG; Carvalho MC; Brandão ML
Neuroscience; 2009 Dec; 164(2):387-97. PubMed ID: 19699782
[TBL] [Abstract][Full Text] [Related]
7. Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test.
Barbalho CA; Nunes-de-Souza RL; Canto-de-Souza A
Brain Res; 2009 Apr; 1267():65-76. PubMed ID: 19268657
[TBL] [Abstract][Full Text] [Related]
8. Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats.
Bertoglio LJ; Anzini C; Lino-de-Oliveira C; Carobrez AP
Behav Brain Res; 2005 Jul; 162(1):99-107. PubMed ID: 15922070
[TBL] [Abstract][Full Text] [Related]
9. Blockade of 5-HT(2) receptors in the periaqueductal grey matter (PAG) abolishes the anxiolytic-like effect of 5-HT(1A) receptor antagonism in the median raphe nucleus in mice.
Nunes-de-Souza V; Nunes-de-Souza R; Rodgers RJ; Canto-de-Souza A
Behav Brain Res; 2011 Dec; 225(2):547-53. PubMed ID: 21839779
[TBL] [Abstract][Full Text] [Related]
10. The dorsal periaqueductal gray modulates the increased fear-like behavior exhibited by experienced rats in the elevated plus-maze.
Kincheski GC; Carobrez AP
Behav Brain Res; 2010 Jan; 206(1):120-6. PubMed ID: 19737580
[TBL] [Abstract][Full Text] [Related]
11. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
[TBL] [Abstract][Full Text] [Related]
12. Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test.
Rezvanfard M; Zarrindast MR; Bina P
Pharmacology; 2009; 84(6):356-66. PubMed ID: 19907194
[TBL] [Abstract][Full Text] [Related]
13. Kaempferol from the leaves of Apocynum venetum possesses anxiolytic activities in the elevated plus maze test in mice.
Grundmann O; Nakajima J; Kamata K; Seo S; Butterweck V
Phytomedicine; 2009 Apr; 16(4):295-302. PubMed ID: 19303276
[TBL] [Abstract][Full Text] [Related]
14. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia.
Albrechet-Souza L; Oliveira AR; De Luca MC; Tomazini FM; Santos NR; Brandão ML
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):571-9. PubMed ID: 15866360
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of 5-HT1A or 5-HT2A receptors in the ventrolateral periaqueductal gray causes anxiolytic-, but not panicolytic-like effect in rats.
de Paula Soares V; Zangrossi H
Behav Brain Res; 2009 Jan; 197(1):178-85. PubMed ID: 18801389
[TBL] [Abstract][Full Text] [Related]
16. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
Gomes KS; Nunes-De-Souza RL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
[TBL] [Abstract][Full Text] [Related]
17. Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory.
Wall PM; Messier C
Psychopharmacology (Berl); 2002 Mar; 160(3):233-44. PubMed ID: 11889492
[TBL] [Abstract][Full Text] [Related]
18. Age-related qualitative shift in emotional behaviour: paradoxical findings after re-exposure of rats in the elevated-plus maze.
Bessa JM; Oliveira M; Cerqueira JJ; Almeida OF; Sousa N
Behav Brain Res; 2005 Jul; 162(1):135-42. PubMed ID: 15922074
[TBL] [Abstract][Full Text] [Related]
19. Activity of the medial prefrontal cortex and amygdala underlies one-trial tolerance of rats in the elevated plus-maze.
Albrechet-Souza L; Borelli KG; Brandão ML
J Neurosci Methods; 2008 Mar; 169(1):109-18. PubMed ID: 18190969
[TBL] [Abstract][Full Text] [Related]
20. Modulation of defensive responses and anxiety-like behaviors by group I metabotropic glutamate receptors located in the dorsolateral periaqueductal gray.
Lima VC; Molchanov ML; Aguiar DC; Campos AC; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):178-85. PubMed ID: 17804134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
